Thyrocare Technologies Ltd. logo

Thyrocare Technologies Ltd. (THYROCARE)

Market Open
10 Aug, 10:00
XNSE XNSE
622. 10
+18.85
+3.1247%
58.75B Market Cap
53.19 P/E Ratio
9.33% Div Yield
341,789 Volume
18.88 Eps
603.25
Previous Close
Add Transaction
Day Range
596.6 624.9
Year Range
342.55 624.9
Want to track THYROCARE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

THYROCARE trading today higher at ₹622.1, an increase of 3.1247% from yesterday's close, completing a monthly increase of 12.1103% or ₹67.2. Over the past 12 months, THYROCARE stock gained 39.7977%.
THYROCARE pays dividends to its shareholders, with the most recent payment made on Jul 29, 2026. The next estimated payment will be in In 5 months on Jan 29, 2027 for a total of ₹7.
The last earnings report, released on May 21, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.07%, based on the last three reports.
Thyrocare Technologies Ltd. has completed 1 stock splits, with the recent split occurring on Nov 28, 2025.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

THYROCARE Chart

People also search for

Cyient Ltd.
856.05
+0.1228%
Kirloskar Oil Engines Ltd.
2,079.9
-2.4071%
Lakshmi Machine Works Limited
17,588
-0.2665%
Blue Dart Express Ltd.
5,136
-1.05%
HBL Power Systems Limited
707
+1.7925%

Thyrocare Technologies Ltd. (THYROCARE) FAQ

What is the stock price today?

The current price is ₹622.10.

On which exchange is it traded?

Thyrocare Technologies Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is THYROCARE.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 9.33%.

What is its market cap?

As of today, the market cap is 58.75B.

Has Thyrocare Technologies Ltd. ever had a stock split?

Thyrocare Technologies Ltd. had 1 splits and the recent split was on Nov 28, 2025.

Thyrocare Technologies Ltd. Profile

Professional Services Industry
Industrials Sector
Mr. Rahul Franklin Guha CEO
XNSE Exchange
Y8T01E103 CUSIP
India Country
1,822 Employees
23 Jun 2026 Last Dividend
28 Nov 2025 Last Split
- IPO Date

Overview

Thyrocare Technologies Limited, established in 1996 and headquartered in Navi Mumbai, India, stands as a pivotal provider of diagnostic testing services across the nation. Catering to patients, laboratories, and hospitals, Thyrocare operates through three main segments: Diagnostic Testing Services, Imaging Services, and Others. The company has carved a niche in the realm of medical diagnostics by emphasizing early detection and management of an array of disorders and diseases. These include, but are not limited to, thyroid-related disorders, growth and metabolism issues, auto-immunity diseases, diabetes, anaemia, cardiovascular conditions, infertility issues, COVID, and various infectious diseases. As a subsidiary of Docon Technologies Private Limited, Thyrocare Technologies Limited continues to advance in its mission to offer comprehensive and quality diagnostic solutions.

Products and Services

Thyrocare Technologies Limited's portfolio encompasses a broad spectrum of products and services aimed at bolstering healthcare diagnostics:

  • Aarogyam Profiles: These are comprehensive wellness and preventive health care test suites marketed under the Aarogyam brand. They are designed to cover a wide range of tests that help in the early detection and management of various health conditions, thus promoting overall well-being.
  • Sugarscan Glucometer and Glucostrips: Under the Sugarscan brand, the company provides glucometers and glucostrips. These products are aimed at patients with diabetes for the monitoring and management of their blood sugar levels, facilitating better diabetes care.
  • Consumables: Thyrocare offers a variety of consumables required for diagnostic testing. These high-quality consumables ensure that the tests are conducted accurately and efficiently, maintaining the integrity of the diagnostic process.
  • Radiopharmaceuticals: The company also deals in radiopharmaceuticals, which are key components in the field of nuclear medicine. These products are used in certain types of imaging services, providing significant insights into various diseases and conditions through advanced diagnostic techniques.

Contact Information

Address: D-37/1, TTC Industrial Area
Phone: 91 22 3090 0000